Navigation Links
Nobel Prize Winner Robert Edwards: A Personal Memoir by the Only American Physician to Participate in Developing IVF

FAIRFAX, Va., Dec. 13, 2010 /PRNewswire-USNewswire/ -- Few people alive today can recount the extraordinary struggles that Drs. Patrick Steptoe and Robert Edwards, the 2010 Nobel Prize winner for Medicine or Physiology, confronted when they defied much of the medical establishment to create in vitro fertilization (IVF) in the 1970s. Now, Dr. Joseph D. Schulman, the only American scientist who worked with Edwards and Steptoe in Britain on the development of IVF, has written a new book, "Robert G. Edwards: A Personal Viewpoint," to share his experiences.  Dr. Steptoe is dead and, tragically, Dr. Edwards was too ill to attend the December 10, 2010 Nobel awards ceremony. Dr. Schulman believes the award was unjustifiably delayed for over twenty years because of Dr. Edwards' unflagging advocacy of reproductive freedom and advances in reproductive medicine.



In describing the early opposition Dr. Edwards faced while working on IVF, Dr. Schulman writes, "Bob had been repeatedly attacked by the sensationalist British press....Colleagues at Cambridge, including the Nobel Laureate Max Perutz, had spoken angrily to Bob about the dangers of what he was trying to do....His research funding from the Medical Research Council (MRC), the British equivalent of the NIH, was threatened....Some of his own graduate students were opposed to what he was attempting, and were intimidated from participation by negative opinions from more senior scientists."

Drs. Edwards and Steptoe proved that the new in vitro fertilization technology could work when the first IVF baby, Louise Brown, was born on July 25, 1978, but the controversy associated with IVF became even more widespread as newspapers trumpeted the birth of the first "test tube baby." Potential parents around the world embraced the technology that could give them children, however, and millions of IVF babies have been born.  The creation of IVF also led to other medical advances that have helped millions of patients.

"Robert G. Edwards: A Personal Viewpoint" is available from for $9.95 per copy.

After graduating from Harvard Medical School, Joseph D. Schulman trained first as a pediatrician and later completed a genetics fellowship at the National Institutes of Health (NIH) from 1968 to 1970. While at NIH, he decided to specialize in the fields of human genetics and reproduction, and subsequently was fully trained in obstetrics and gynecology at the New York Hospital-Cornell Medical Center.  Following his work with Drs. Edwards and Steptoe, Dr. Schulman was the first director of the Medical Genetics Program at NIH, where he was a research scientist and served on the faculty for ten years. In 1984, Dr. Schulman founded Genetics & IVF Institute (GIVF), headquartered in Fairfax, VA, to provide cutting edge infertility and genetic diagnosis and treatment.  GIVF is responsible for more than 20,000 pregnancies around the world.  Now retired from active practice, Dr. Schulman continues to serve as Chairman of GIVF's Board of Directors.

SOURCE Genetics & IVF Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene pioneers follow in Nobel footsteps
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
5. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
6. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
7. Thomson Reuters Predicts Nobel Laureates
8. Expands Channels and News Services for the 2009 Nobel Prize Announcements
9. Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel
10. BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge
11. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
Post Your Comments:
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... June 23, 2016 ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... . The Global Cell ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
Breaking Biology News(10 mins):